NeoStem, Inc. Closes Divestiture of Its Ownership Interest in Suzhou Erye Pharmaceuticals Company Ltd.
11/13/2012 8:09:18 AM
More...
|
NeoStem, Inc. Signs a Definitive Agreement to Divest Its 51% Ownership Interest in Suzhou Erye Pharmaceuticals Company Ltd.
6/18/2012 9:44:22 AM
More...
|
Capacity Constraints Continue to Loosen for Suzhou Erye Pharmaceuticals Company Ltd. as a New Production Line is Approved by the China SFDA
6/13/2011 9:02:10 AM
More...
|
NeoStem, Inc.'s Suzhou Erye Pharmaceuticals Company Ltd. Receives Two Awards at the Chempharm Brand Summit 2011
4/26/2011 7:29:37 AM
More...
|
Suzhou Erye Pharmaceuticals Company Ltd.'s Suzhou Erye Pharmaceutical Subsidiary Passes Government Inspection for Two Significant Manufacturing Lines in its New Facility
6/15/2010 10:53:10 AM
More...
|
NeoStem, Inc.'s Suzhou Erye Pharmaceuticals Company Ltd. Subsidiary Receives Approval to Manufacture Generic Cloxacillin
4/5/2010 8:47:40 AM
More...
|
NeoStem, Inc.'s Suzhou Erye Pharmaceuticals Company Ltd.l Subsidiary Receives Approval for First Two Manufacturing Lines in its New Facility
2/1/2010 11:27:55 AM
More...
|
NeoStem, Inc. Raises Additional Funds from Principals of Suzhou Erye Pharmaceuticals Company Ltd. and U.S. Institutional and Private Investors, Bringing the Total Recent Financings to Over $15 Million
7/1/2009 7:29:19 AM
More...
|